Celeris Therapeutics
Targeted protein degraders for unmet diseases.
What is the issue to solve?
Limited treatment options for diseases with high unmet medical need.
What’s their solution?
Designing targeted protein degraders using machine learning to treat diseases with high unmet medical need.
Who is their product for?
Biotech and pharmaceutical companies, venture capitalists, and investors.
Competitors
AI Disclaimer
We have generated these company profiles using AI and feeding it the companies website. Because of that we cannot guarantee the accuracy and we welcome any feedback, we will promptly change any inaccuracies.
Thank you!